Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the disallowance of sales promotion or distribution expenses paid to Welable Pharma, by restricting such expenditure from 13.5% to 5% of sales, was sustainable.
Analysis: The assessee's compensation arrangement with the distributor was examined in the light of the past years' figures and the overall profit margin reflected after credit notes. The Tribunal found the method consistently followed by the assessee and saw no basis to disturb the declared profit on the facts presented.
Conclusion: The disallowance was not sustained and the assessee succeeded on the issue.
Final Conclusion: The appeal was allowed and the addition made by restricting the sales promotion or distribution was deleted.
Ratio Decidendi: Where the assessee follows a consistent commercial arrangement and the declared profit is not shown to be unreasonable, the expenditure cannot be disallowed merely by substituting a different percentage on a broad market-limit basis.